Back to top
Clinical stage:
In vitro

N4 Pharma has filed a patent for the reformulation of the anti-depressant drug, paroxetine, to develop a new product for the treatment of hot flashes and night sweats in menopausal women. Paroxetine has already been approved for these treatments by the FDA. The market for menopausal hot flashes drugs is forecast to grow annually from $3.8bn in 2014 to $5.3bn by 2023*

*Source: http://www.prnewswire.com/news-releases/menopausal-hot-flashes-market-to-reach-us528-bn-by-2023-estrogen-leads-hormonal-products-in-revenue-and-prescription-volume-564235661.html